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Piperine is a phytochemical present in black pepper (Piper nigrum Linn) and other
related herbs, possessing a wide array of pharmacological activities including anti-
inflammatory effects. Previously, we demonstrated that piperine has therapeutic effects
on bacterial sepsis in mice, but the underlying mechanism has not been fully
elucidated. In this study, we aimed to investigate the influences of piperine on
pyroptosis in murine macrophages. The results showed that piperine dose-dependently
inhibited ATP-induced pyroptosis, thereby suppressing interleukin-1β (IL-1β) or high
mobility group box-1 protein (HMGB1) release in LPS-primed bone marrow-derived
macrophages and J774A.1 cells. Accompanying this, ATP-induced AMP-activated
protein kinase (AMPK) activation was greatly suppressed by piperine, whereas AMPK
agonist metformin counteracted piperine’s inhibitory effects on pyroptosis. Moreover,
piperine administration greatly reduced both peritoneal and serum IL-1β levels in the
mouse model intraperitoneally infected with Escherichia coli, suggestive of suppressing
systemic inflammation and pyroptosis. Our data indicated that piperine could protect
macrophages from pyroptosis and reduced IL-1β and HMGB1 release by suppressing
ATP-induced AMPK activation, suggesting that piperine may become a potential
therapeutic agent against bacterial sepsis.
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INTRODUCTION
Piperine is an alkaloid present in black pepper (Piper nigrum Linn) and other related herbs
(Wattanathorn et al., 2008). This alkaloid has been reported to possess a broad spectrum of
pharmacological activities. It is well known for its anti-depressive and anti-epileptic activities
(Pal et al., 2011; Mao et al., 2014). It is also known as a booster for promoting bioavailability
of other drugs thus enhancing their pharmacological effects (Johnson et al., 2011; Di et al.,
2015). Interestingly, piperine has been demonstrated to be a potential agent with anti-obesity
(BrahmaNaidu et al., 2014), anti-gastric ulcer (Bai and Xu, 2000), anti-acute pancreatitis (Bae G. S.
et al., 2011), and anti-arthritis (Murunikkara et al., 2012; Ying et al., 2013) properties. Moreover,
piperine is also effective for the treatment of diarrhea (Mehmood and Gilani, 2010) and endotoxin-
induced septic shock in mice (Bae et al., 2010). Therefore, piperine may be generally regarded as
an anti-inflammatory agent against various inflammatory disorders as a consequence of bacterial
infections or autoimmune responses.
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Recently, we have demonstrated that piperine administration
reduces mouse mortality, and alleviates their internal organ
damages upon bacterial infection (Pan et al., 2015). One
potential mechanism is that piperine treatment promotes amino
acid metabolism and thus enhances mTORC1 signaling in
peritoneal resident macrophages. The functions of the peritoneal
macrophages are greatly enhanced in terms of their bacterial
phagocytic ability and their cytokine secretion ability upon
inflammatory stimulation (Pan et al., 2015). However, it is still
unclear how piperine prevents internal organs from injury under
the circumstance of systemic inflammatory responses during
bacterial sepsis.
One consequence of bacterial infection is inflammasome
activation. The inflammasome is a multiple protein complex
and its activation represents the first line of innate defense
against bacterial infection (Lamkanfi and Dixit, 2014; Wegiel
et al., 2014). The activation of inflammasome requires two
signals. First, the innate immune cells is primed by recognizing
the pathogen-associated molecular patterns (PAMPs) expressed
on the pathogen through their pattern recognition receptors
(PRRs), resulting in the expression of critical components of
inflammasome, such as nucleotide and oligomerization domain,
leucine-rich repeat containing protein family, pyrin containing
domain 3 (NLRP3) and pro-interleukin-1β (pro-IL-1β). Second,
the inflammasome is assembled in the PAMP-primed cells upon
further stimulation by damage-associated molecular patterns
(DAMPs) such as ATP, culminating in recruitment of the
apoptosis-associated speck-like protein containing CARD (ASC)
adaptor protein. Consequently, pro-caspase-1 is activated by the
inflammasome to produce the active caspase-1, which further
converts pro-IL-1β into mature form IL-1β (Lamkanfi and
Dixit, 2014). The latter is a potent endogenous pyrogen that
promotes an increase in body temperature as well as mediating
inflammatory responses. Beyond the release of mature IL-
1β, one prominent consequence of inflammasome activation
is pyroptosis—an inflammatory programmed cell death, which
is dependent on the activation of inflammatory caspase-1 or
caspase-11. Activated caspase-1 or caspase-11 can cleave the
gasdermin D to release its N-terminal fragment which is critical
for pyroptosis (Shi et al., 2014; Kayagaki et al., 2015). Therefore,
induction of pyroptosis requires both PAMP and DAMP
stimulation, as having been elegantly evaluated recently (Cullen
et al., 2015), constituting the canonical inflammasome signaling.
In non-canonical inflammasome signaling, lipopolysaccharide
(LPS), upon penetrating into the cell, directly binds caspase-11
and activates it, leading to caspase-1 activation and pyroptosis
(Shi et al., 2014; Kayagaki et al., 2015).
Many studies have indicated that inflammasome activation
and pyroptosis provide protection against bacterial infection
(Ceballos-Olvera et al., 2011) and experimental colitis (Zaki
et al., 2010; Demon et al., 2014; Oficjalska et al., 2015).
Without the protection of inflammasome mechanism due to
lack of caspase-1 and caspase-11 genes, mice are vulnerable to
intracellular bacterial infection (Maltez et al., 2015). However,
increasing evidence has indicated that pyroptosis may be a
major cause that leads to multiple organ failure and septic
death (Masters et al., 2012; Wree et al., 2014). In support
of this notion, mice are resistant to bacterial-induced death
when the pyroptotic mechanism is lost due to caspase-11 and
gasdermin D deficiency (Kayagaki et al., 2015). Although it
has once believed that ‘cytokine storm’ is the main cause of
sepsis, recent studies have proved that septic death can still take
place in mice lacking caspase-1 activation and IL-1β production
(due to caspase-1 gene deletion but retaining of caspase-11
gene), reinforcing the idea that caspase-11-mediated pyroptosis
is critical for septic shock (Kayagaki et al., 2013). However,
the release of IL-1β may still be regarded as a marker of
pyroptosis, as one recent study has proved that it can only be
released by pyroptotic cells instead of viable ones (Cullen et al.,
2015).
In this study, we aimed to investigate whether piperine could
suppress pyroptosis in macrophages. By using in vitro cell models
where mouse bone marrow-derived macrophages (BMDMs)
and J774A.1 cells were primed with LPS (a Gram-negative
bacterial PAMP) followed by triggering with extracellular ATP
[a DAMP released by hosts or bacteria (Mempin et al., 2013;
Ren et al., 2014; Wegiel et al., 2014)], we found that piperine
treatment significantly suppressed ATP-induced pyroptosis,
which was associated with suppression of AMPK activity.
Piperine administration markedly reduced IL-1β levels in the
peritoneal lavage fluids and serum of mice with bacterial sepsis
as compared with vehicle, indicating attenuation of systemic
inflammation in the circumstance of bacterial sepsis. Our data
suggest that piperine may be used to prevent bacterial sepsis by
suppression of pyroptosis.
MATERIALS AND METHODS
Reagents and Animals
Propidium iodide (PI), dimethyl sulfoxide (DMSO), Hoechst
33342, adenosine triphosphate (ATP) (P8232) and LPS (from
Escherichia coli O111:B4) (L4391) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Piperine was purchased from
Guangdong Institute for Drug Control (Guangzhou, China),
dissolved in DMSO and stored at −20◦C. DMEM, fetal bovine
serum (FBS), penicillin and streptomycin were products of
ThermoFisher/Gibco (Carlsbad, CA, USA). Metformin was
obtained from MedChem Express (Princeton, NJ, USA),
dissolved in DMEM at 300 mM and stored at −20◦C.
The antibody to NLRP3 (AG-20B-0014) was purchased from
Adipogen AG (Liestal, Switzerland). Antibodies against caspase-
1p10 (sc-514) and actin (sc-1616-R) were obtained from
Santa Cruz (Santa Cruz Biotechnology, Dallas, TX, USA).
Antibodies against IL-1β (#12242), HMGB1 (#3935), AMPKα
(#5832), phospho(p)-AMPKα(Thr172) (#2535), p70S6K (#2708),
p-p70S6K(Thr389) (#9234), caspase-3 (#9662), β-tubulin (#2128)
and horseradish peroxidase (HRP)-conjugated goat anti-mouse/-
rabbit/-rat IgG were bought from Cell Signaling Technology
(Danvers, MA, USA).
Female C57BL/6 mice were bought from the Experimental
Animal Center of Southern Medical University (Guangzhou,
China). Animal experiments were designed following the
National Institutes of Health guidelines and were approved by
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the Committee on the Ethics of Animal Experiments of Jinan
University.
Cell Line and Cell Culture
The J774A.1 cells was obtained from the Kunming Cell Bank
of Type Culture Collection, Chinese Academy of Sciences
(Kunming, China) and maintained in DMEM supplemented with
10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, and
2 mM L-glutamine (DMEM complete medium) at 37◦C in a
humidified incubator of 5% CO2. The cells were sub-cultured
every 2–3 days.
Bone Marrow-Derived Macrophages
(BMDMs)
Bone marrow was collected from femora of C57BL/6 mice.
BMDMs were differentiated as reported previously (Kayagaki
et al., 2013). In brief, bone marrow cells were differentiated in
DMEM supplemented with 10% FBS and 20% (v/v) M-CSF-
conditioned medium from L-929 fibroblasts for 6 days. BMDMs
were then cultured in fresh DMEM complete medium overnight
in 24-well plates at 1.5× 105 cells/well in 0.5 ml.
Pyroptotic Assay
Cell death was measured by PI incorporation as described
previously (Py et al., 2014). Cells were pre-treated with indicated
concentration of piperine for 4 h in DMEM complete medium,
and then primed with 500 ng/ml LPS for 4 h. Subsequently,
the culture medium was replaced with Opti-MEM and indicated
concentrations of ATP. Cell nuclei were revealed by Hoechst
33342 staining (5 µg/ml; staining for all cells) and PI (2 µg/ml;
staining for pyroptotic cells) for 10 min. The cells were observed
using a Zeiss Axio Observer D1 microscope equipped with
a Zeiss LD Plan-Neofluar 20×/0.4 Korr M27 objective lens.
Fluorescence images were captured with a Zeiss AxioCam MR
R3 cooled CCD camera controlled with ZEN software (Carl
Zeiss).
Cytometric Bead Array
Soluble IL-1β was determined by cytometric bead array (CBA)
using the Mouse IL-1β Flex Set (BD Biosciences, San Jose,
CA, USA) according to the manufacturer’s instructions. Data
were acquired using CELLQuest software on a flow cytometer
(FACSCalibur; Becton Dickinson, Mountain View, CA, USA).
Precipitation of Soluble Proteins in
Supernatants
Proteins in culture supernatants (equal volume for each sample)
were precipitated overnight with 7.2% trichloroacetic acid plus
0.15% sodium deoxycholate as previously described (Lin et al.,
2016). The precipitates are lysed in equal volume of 1x sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
loading buffer.
Western Blot Analysis
Western blotting was performed as described previously (Lin
et al., 2016) to detect proteins in the supernatants and cell lysates,
respectively. In brief, total proteins were separated by SDS-PAGE
and transferred onto a PVDF membrane (Amersham, RPN303F).
After being blocked, the membranes were probed with indicated
primary antibodies, followed by a HRP-conjugated goat anti-
rabbit IgG or goat anti-mouse IgG. Bands were revealed by a
BeyoECL Plus kit (Beyotime, P0018) and recorded on X-ray
films (Kodak, 6535873). The densitometry of each band was
quantified by FluorChem 8000 (Alpha Innotech; San Leandro,
CA, USA).
Bacterial Infection
C57BL/6 mice were acclimated for 1 week and intragastrically
administered with piperine solution or vehicle (2% Tween-80 in
PBS) once a day for 5 consecutive days. E. coli strain DH5α was
grown in Luria Broth (LB) media and the bacterial cell density
was determined using an ultraviolet-visible spectrophotometer
(NanoDrop2000, Thermo Scientific). The colony-forming units
(CFUs) corresponding to known cell densities were determined
on LB agar plates. The mice were intraperitoneally (i.p.) injected
with 2 × 109 CFU/mouse of viable E. coli cells in 0.5 ml of
PBS. After bacterial infection for indicated time lengths, the
mice were sacrificed and peritoneal lavage fluids were collected
with 1.5 ml PBS for IL-1β determination by CBA. The colon
tissues were also collected for western blotting analysis. In a
separate experiment, mouse sera were collected from retro-
orbital venous blood and IL-1β in serum was assayed by CBA
method.
Statistical Analysis
All experiments were performed independently at least three
times, with one representative experiment shown. Data are
presented as mean± standard deviation (SD). Statistical analysis
was performed using Graphpad Prism 4.0 (GraphPad; San Diego,
CA, USA). One-way analysis of variance (ANOVA) followed
by Tukey post hoc test and unpaired Student’s t-test were used
to analyze the statistical significance among multiple groups
and between two groups, respectively. P-values < 0.05 were
considered statistically significant.
RESULTS
Piperine Inhibits ATP-Induced Pyroptosis
in BMDMs
Our previous work demonstrated that piperine administration
significantly alleviated injury of internal organs and reduced
mouse mortality in bacterial sepsis (Pan et al., 2015). As
pyroptosis has been reported being causative of sepsis-induced
organ damages, we explored whether piperine could suppress
pyroptosis in LPS-primed macrophages upon ATP triggering.
We firstly evaluated the effects of piperine on ATP-induced
pyroptosis, which can be revealed by PI staining (Py et al.,
2014). BMDMs were pretreated with piperine followed by LPS
priming (in the presence of piperine) and were then triggered by
ATP treatment (without LPS and piperine). The results showed
that LPS priming did not induce pyroptosis in BMDMs, and
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piperine at a dose up to 160 µM was non-toxic to the cells
during short periods of incubation (Figures 1A,B). Upon ATP
triggering, however, the LPS-primed BMDMs rapidly underwent
pyroptosis. Interestingly, piperine pretreatment significantly
attenuated ATP-induced pyroptosis in a dose-dependent manner
(Figures 1A,B).
It has been demonstrated that in LPS-primed macrophages
ATP treatment activates NLRP3 inflammasome leading to pro-
caspase-1 processing into active caspase-1p10; the latter in
turn cleaves pro-IL-1β (31 kDa) to produce a 17-kDa IL-1β
(mature form) while pyroptosis is induced and mature IL-1β is
released from the pyroptotic cells rather than the living ones
(Cullen et al., 2015). Therefore, the levels of mature IL-1β and
active caspase-1p10 in cell culture supernatants are markers
of inflammasome activation and pyroptosis. Consistent with
these reports (Latz et al., 2013; Cullen et al., 2015), western
blotting results showed that LPS priming greatly induced the
expression of pro-IL-1β in the cells, whereas pro-caspase-1 was
constitutively expressed in BMDM cells (Figure 1C). Without
ATP treatment, both active caspase-1p10 and mature IL-1β were
undetectable in the supernatants either treated with piperine
or not; upon ATP triggering, they were significantly released
into the supernatants, reflective of inflammasome activation and
pyroptosis. Notably, piperine pretreatment dose-dependently
suppressed the release of both active caspase-1p10 and mature
IL-1β into the supernatants (Figures 1C–E). Together, these
results indicated that piperine pretreatment could significantly
attenuated ATP-induced pyroptosis, thus reducing IL-1β release,
in LPS-primed BMDMs.
Piperine Suppresses ATP-Induced
Pyroptosis in J774A.1 Cells
Next, we examined the effects of piperine on ATP-induced
pyroptosis in LPS-primed murine J774A.1 macrophage cell
line. Piperine pretreatment dose-dependently suppressed ATP-
induced pyroptosis as in BMDMs (Figures 2A,B). Consistently,
ATP treatment induced the release of HMGB1, another danger
signal molecule that is associated with inflammatory cell death
(de Souza et al., 2012; Gdynia et al., 2016). Piperine pretreatment
once again suppressed the effect of ATP on HMGB1 release
(Figures 2C,D). As IL-1β release in the supernatants was hardly
detectable by western blotting, we used a more sensitive CBA
method (with a detection limit of ∼5 pg/ml) to measure soluble
IL-1β levels. The result showed that piperine pretreatment
significantly inhibited ATP-induced IL-1β release (Figure 2E).
This is likely because piperine had directly suppressed the
expression of pro-IL-1β in the cells treated with LPS plus ATP
(Figure 2C, cell lysate). Apoptosis had not been involved in
ATP-induced cell death, as caspase-3 cleavage (activation) was
not observed in all groups (Figure 2C). Together, these results
indicated that piperine treatment could suppress pyroptosis and
reduced IL-1β and HMGB1 release in J774A.1 cells in response to
ATP triggering.
Based on the above-mentioned results from both BMDMs and
J774A.1 cells, piperine treatment could inhibit the pyroptosis in
LPS-primed macrophages in response to ATP triggering.
ATP-Induced AMPK Activation Is
Suppressed by Piperine Treatment
It has been shown that AMPK activity is suppressed by
LPS, free fatty acid, and other inflammatory stimulators (Yang
et al., 2010; Wen et al., 2011; Wang et al., 2016). However,
AMPK signaling can be activated by bacterial infection (Bae
H. B. et al., 2011) while the suppressed AMPK activity in
LPS-primed macrophages can be dramatically activated (as
reflected by its phosphorylation at Thr172) in response to
ATP treatment (Bae H. B. et al., 2011; Moon et al., 2015).
Consistent with these reports, we also observed that AMPK
activity was suppressed by LPS but greatly increased in
both LPS-primed BMDMs (Figures 3A,B) and J774A.1 cells
(Figures 3C,D) upon ATP stimulation. Interestingly, ATP-
induced AMPK activation could be markedly suppressed by
piperine pretreatment (Figures 3A–D). Consistent with our
previous study (Pan et al., 2015), piperine could increase the
phosphorylation of p70S6K, indicative of enhanced mTORC1
activity, in macrophages (Figure 1A). In line with the activation
of AMPK upon ATP treatment, the mTORC1 activity was
sharply suppressed by ATP. These results in conjunction with
previous studies suggested that AMPK signaling may regulate cell
survival and death under inflammatory stresses. Our results also
suggested that piperine might inhibit ATP-induced pyroptosis by
suppressing AMPK activation.
Piperine Attenuates Pyroptosis by
Suppressing AMPK Signaling
Having found that AMPK activity was associated with piperine-
mediated suppression of pyroptosis in macrophages in
response to ATP stimulation, we next investigated whether
such suppressive effects of piperine could be counteracted
by boosting AMPK signaling with metformin, a well-known
AMPK agonist (Su and Dai, 2016). As expected, metformin
could reverse piperine-mediated suppression of AMPK activity
in macrophages in response to LPS and ATP stimulation
(Figures 4A,B). Notably, metformin treatment counteracted
piperine-mediated suppression of HMGB1 release from
J774A.1 cells (Figure 4C, supernatant). Metformin treatment
also counteracted the inhibitory effect of piperine on ATP-
induced active caspase-1p10 release from BMDMs, but the
reduced IL-1β release induced by ATP in the presence of
piperine was not completely restored by metformin. This
was likely due to that the expression of pro-IL-1β was
greatly suppressed by piperine of 160 µM in LPS+ATP-
treated BMDMs (Figure 4D, cell lysate). Consistent with
these results, metformin fully reversed the effect of 80
µM piperine on suppressing ATP-induced pyroptosis in
BMDMs (Figures 5A,B) and J774A.1 cells (Figures 5C,D),
while partially reversing the inhibitory effect of 160 µM
piperine on ATP-induced pyroptosis in BMDMs (Figure 5B)
probably due to the robust inhibitory effect of this high-
dose piperine. These results demonstrated that piperine
pretreatment protected LPS-primed macrophages from ATP-
induced pyroptosis by at least partly suppressing AMPK
activation.
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FIGURE 1 | Piperine inhibited ATP-induced pyroptosis in bone marrow-derived macrophages (BMDMs). (A) Cells were pre-treated with graded
concentrations of piperine for 4 h, followed by LPS (500 ng/ml) priming for 4 h (in the presence of piperine). Then the cells were stimulated with ATP (3 mM) for
30 min (in the absence of piperine and LPS). After these treatments, the cells were stained with 2 µg/ml propidium iodide (PI; red, staining dead cells) plus 5 µg/ml
Hoechst 33342 (blue, staining all cells) for 10 min, and observed with fluorescent microscopy. One set of representative images of three independent experiments
are shown. Bright-field images are also shown in merge. PIP, piperine. Scale bar, 50 µm. (B) PI-positive cells in five random fields (around 100 cells per field) were
calculated and statistically analyzed. Data are shown as mean ± SD (n = 5). (C) Cells were treated as in (A). The equal volumes of culture supernatants were
collected and the proteins in the supernatants were precipitated overnight with 7.2% trichloroacetic acid plus 0.15% sodium deoxycholate. After centrifugation at
13,000 × g for 30 min, the pellets were lysed in equal volume of 1x SDS-PAGE loading buffer. Total proteins precipitated from equal volumes of supernatants were
loaded for western blotting. The cells were lysed with 1× SDS-PAGE loading buffer. Equal amounts of proteins in the cell lysates were loaded for western blotting.
β-Tubulin was recruited as a loading control in cell lysates. (D,E) Relative gray values of IL-1β (D) and caspase-1p10 (E) blots from respective supernatants were
quantified. Data are shown as mean ± SD (n = 3). Statistical significance was analyzed by one-way ANOVA with Tukey post hoc test. ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001; ns, not significant.
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FIGURE 2 | Piperine suppressed ATP-induced pyroptosis in J774A.1 cells. (A) Cells were pre-treated with graded doses of piperine for 4 h, followed by LPS
(500 ng/ml) priming for 4 h (in the presence of piperine). Then the cells were stimulated with ATP (4 mM) for 1 h (in the absence of piperine and LPS). Pyroptotic cells
were stained with 2 µg/ml propidium iodide (PI) plus 5 µg/ml Hoechst 33342 for 10 min, and observed by fluorescent microscopy. Bright-field images are also
shown in merge. PIP, piperine. Scale bar, 50 µm. (B) PI-positive cells in 5 random fields (around 150 cells per field) were calculated for each group. Data are shown
as mean ± SD (n = 5). (C) Cells were treated as in (A). Proteins in cell lysates and culture supernatants were evaluated by western blotting. β-Tubulin was used as a
loading control for cell lysates. (D) Relative gray values of HMGB1 blots from respective supernatants are shown as mean ± SD (n = 3). (E) IL-1β levels in the cell
culture supernatants were evaluated by cytometric bead array (CBA) assay according to the manufacturer’s instructions. Data are shown as mean ± SD (n = 3).
Statistical significance was analyzed by one-way ANOVA with Tukey post hoc test. *P < 0.05, **P < 0.01, ***P < 0.001.
Piperine Administration Reduces
Systemic IL-1β Release in Mouse
Bacterial Sepsis
Previously, we have demonstrated that piperine administration
in vivo can protect mice from bacterial infection and that
the mice having received piperine administration showed less
mortality and histological injuries in their liver and colon as
compared to the vehicle group (Pan et al., 2015). In this study,
we further investigated whether piperine administration reduced
IL-1β release in C57BL/6 mice upon bacterial infection. The
results showed that bacterial infection induced IL-1β release
into the peritoneal lavage fluids and blood in a time-dependent
manner (Figures 6A,B). Piperine administration significantly
reduced IL-1β levels both in the peritoneal lavage fluids and
serum (Figures 6A,B), suggesting that bacterial-induced systemic
inflammation and pyroptosis was suppressed by piperine.
Western blotting also demonstrated that bacterial infection
increased both pro-IL-1β and mature IL-1β (17 kDa) expression
in the colonic tissues, suggesting inflammasome activation in
the colon, which might be infected by bacteria injection in
the peritoneal cavity. Piperine administration greatly suppressed
the expression of pro-IL-1β and IL-1β in the colonic tissues
(Figures 6C–E), which was likely to reduce the secretion of IL-1β
from the colon. Altogether, these results suggested that piperine
administration could inhibit systemic inflammatory responses
during bacterial sepsis, probably through suppressing pyroptosis
of activated immune cells including macrophages.
DISCUSSION
It has been shown that piperine exhibits anti-septic effects
in a mouse model of bacterial sepsis probably by boosting
Frontiers in Pharmacology | www.frontiersin.org 6 October 2016 | Volume 7 | Article 390
fphar-07-00390 October 18, 2016 Time: 14:46 # 7
Liang et al. Suppression of Pyroptosis by Piperine
FIGURE 3 | Piperine attenuated ATP-induced AMPK activation in macrophages. BMDMs (A,B) or J774A.1 cells (C,D) were pre-treated with graded
concentrations of piperine for 4 h, followed by LPS (500 ng/ml) priming for 4 h before ATP (3 mM) stimulation for 30 min (BMDMs) or ATP (4 mM) stimulation for 1 h
(J774A.1 cells), respectively, as mentioned in Figure 1. (A,C) The cells were lysed by 1x SDS-PAGE loading buffer and equal amounts of the total proteins in each
sample were analyzed by western blotting with indicated antibodies. β-Tubulin was recruited as a loading control. (B,D) The densitometry ratios of p-AMPK relative
to AMPK of BMDMs (B) or J774A.1 cells (D) were analyzed. Data are presented as mean ± SD (n = 3). Statistical significance was analyzed by one-way ANOVA
with Tukey post hoc test. ***P < 0.001.
the functions of peritoneal resident macrophages through the
upregulation of mTORC1 signaling (Pan et al., 2015). However,
this may not thoroughly explain why piperine has alleviated
the damages to internal organs upon bacterial infection. In
this study, we further demonstrated that piperine treatment
decreased ATP-induced pyroptosis and IL-1β release in LPS-
primed macrophages in vitro, and suppressed IL-1β expression
and release in vivo in the same murine septic model. These
data strongly suggest that piperine may have suppressed
pyroptosis in vivo in the circumstance of bacterial infection,
thereby protecting mice from septic death by reducing systemic
inflammatory responses as well as organ damages.
Sepsis is a worldwide medical problem, since the pathological
progression from systemic infection to septic shock or death
can be very fast and there are at present no therapeutic drugs
to prevent it (Dellinger et al., 2013). One consequence of
sepsis is multiple organ failure in the patients. Several cell
death types, including apoptosis, necrosis and pyroptosis, have
been implicated in this process (Aziz et al., 2014). However,
recent studies tend to agree that pyroptosis is the major cause
of organ injury from sepsis (Wree et al., 2014; Kayagaki
et al., 2015). Indeed, hepatic pyroptosis due to hyperactive
NLRP3 inflammasome has been found to contribute to liver
damage (Wree et al., 2014). Consistent with this concept,
mice with caspase-1/-11 or gasdermin D gene deletion, thus
lacking inflammasome activation and pyroptosis, are resistant
to endotoxin-induced sepsis (Kayagaki et al., 2011, 2015). In
further support of this, inhibition pyroptosis by neutralization of
LPS with antimicrobial peptide LL-37 significantly protects mice
from cecal ligation and puncture (CLP)-induced death (another
commonly used septic mouse model) (Hu et al., 2016). Therefore,
preventing pyroptosis during bacterial infection should alleviate
sepsis-associated multiple organ failure and pathological process.
Pyroptosis can be induced by ATP treatment in LPS-primed
macrophages in vitro. Such a cellular pyroptotic model may
represent a severe circumstance of in vivo infection, since
ATP can be released by both bacteria and host cells during
bacterial infection (Mempin et al., 2013; Ren et al., 2014). In this
study, we demonstrated that piperine pretreatment suppressed
ATP-induced pyroptosis in LPS-primed macrophages in vitro,
which was evidenced by the reduction of soluble mature IL-
1β, active caspase-1p10 and HMGB1 in the supernatants of
piperine-pretreated macrophages. One reason for the reduced
soluble mature IL-1β levels might be due to piperine-mediated
suppression of pyroptosis. A second reason was likely due to that
high doses of piperine significantly reduced the pro-IL-1β level in
LPS-primed BMDMs irrespective of ATP treatment (Figure 1C)
as well as in LPS-activated J774A.1 cells in the presence of ATP
(Figure 2C). The precise mechanism underlying reduced pro-IL-
1β levels is unknown but it is probably that a high dose of piperine
may influence the expression of pro-IL-1β at transcriptional and
translational levels or at post-translational levels. Importantly,
piperine may also suppressed in vivo pyroptosis in the murine
bacterial septic model, as reflected by reduced mature IL-1β
levels in serum and infected sites. Consistent with the in vitro
observation, piperine administration also down-regulated the
pro-IL-1β levels in the colon, which might also contribute to
reduced mature IL-1β levels in this tissue (Figures 6C,D). As
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FIGURE 4 | Metformin, an AMPK agonist, counteracted the effect of piperine on suppressing ATP-induced AMPK activation and inflammatory
mediator release. J774A.1 cells (A–C) were pre-treated with 80 µM piperine and BMDMs (D) were pre-treated with 160 µM piperine for 4 h. Without being washed
out of piperine, these cells were primed with LPS (500 ng/ml) for 4 h. Next, the cells were treated with metformin (1 mM) for 1 h (in the absence of piperine and LPS).
Finally, in the presence of metformin, the BMDMs were stimulated with 3 mM ATP (final concentration) for 30 min while the J774A.1 cells were treated with 4 mM
ATP (final concentration) for 1 h. After the cells were lysed with 1x SDS-PAGE loading buffer, protein levels were evaluated by western blotting (A,C,D). β-Tubulin was
used as a loading control for cell lysates. (B) The densitometry ratios of p-AMPK relative to AMPK in the blots of (A) were analyzed by FluorChem 8000 (Alpha
Innotech). Data are presented as mean ± SD (n = 3). Statistical significance was analyzed by one-way ANOVA with Tukey post hoc test. ∗P < 0.05, ∗∗P < 0.01.
pyroptosis has a critical role in septic shock (Wree et al., 2014;
Kayagaki et al., 2015), reduced pyroptosis by piperine may
diminish the injury of organs. Indeed, piperine administration
in vivo alleviated injuries of internal organs and reduced mouse
mortality upon bacterial infection (Pan et al., 2015). This is
consistent with a previous study showing that piperine can inhibit
LPS-induced endotoxin shock, although there was no reduction
in IL-1β levels in serum (detected at 3 h post LPS injection) of
mice treated with piperine intraperitoneally (Bae et al., 2010).
The discrepancy between their results and ours may be due to the
differences of animal models and drug administration routes. In
our study, the mice were directly infected with viable bacteria and
piperine was given intragastrically. Moreover, the release of IL-1β
in our experimental model was time-dependent and we observed
varied serum IL-1β levels in the vehicle and piperine groups
at 6 and 12 h. It is unclear whether piperine also suppressed
serum IL-1β levels in LPS-inoculated mice in a time-dependent
manner.
Chronic inflammations including autoimmune diseases
are associated with inflammasome activation (Yang and
Chiang, 2015; Zhang et al., 2016). Negative regulation of
the inflammasome activation is believed to ameliorate these
diseases (Vande Walle et al., 2014), whereas release of IL-1β,
IL-18, HMGB1 or uric acid may induce or aggravate disease
symptoms (Lamkanfi et al., 2011; Yang and Chiang, 2015).
Piperine has been reported to prevent chronic inflammatory
diseases, including epilepsy (Pal et al., 2011) and arthritis
(Umar et al., 2013). Some studies have indicated or implied
that piperine alleviates chronic inflammatory diseases (such as
diabetic nephropathy (Samra et al., 2016) and arthritis (Ying
et al., 2013)) by suppressing inflammasome activation and
thus inhibiting IL-1β release. Consistent with our study, one
recent report indicated that piperine inhibits periodontitis in
a rat model at a dose of 100 mg/kg (Dong et al., 2015). This is
likely due to its inhibitory effect on the expression of IL-1β (or
pro-IL-1β), matrix metallopeptidase (MMP)-8 and MMP-13 in
the local gingiva tissues. However, it is unclear whether piperine
suppresses pyroptosis and IL-1β release in the gingiva tissues of
the periodontitis model.
It is of importance to uncover the underlying mechanism
by which piperine suppressed pyroptosis and IL-1β release.
Our previous study has demonstrated that piperine treatment
promotes amino acid metabolism to enhance mTORC1 signaling
(Pan et al., 2015). Therefore, we investigated whether piperine
influenced the mTORC1 signaling in LPS-primed macrophages
upon ATP stimulation. Our results demonstrated that the
mTORC1-p70S6K pathway was greatly activated in macrophages
by LPS priming, but was completely suppressed by ATP treatment
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FIGURE 5 | Metformin reversed piperine’s effect on suppression of pyroptosis in macrophages treated with ATP. BMDMs (A,B) or J774A.1 cells (C,D)
were pre-treated with indicated concentrations of piperine (BMDMs) or 80 µM piperine (J774A.1) for 4 h, and then primed with LPS (500 ng/ml) for 4 h in the
presence of piperine. After washing out of piperine and LPS, the cells were then treated with metformin (1 mM) for 1 h followed by 3 mM ATP for 30 min (BMDMs) or
4 mM ATP for 1 h (J774A.1 cells) in the presence of metformin. The pyroptotic cell ratios in BMDMs (B) or J774A.1 cells (D) were evaluated as described in
Figure 1. Data are presented as mean ± SD (n = 5). Statistical significance was analyzed by one-way ANOVA with Tukey post hoc test. ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001. PIP, piperine; Met, metformin.
(Figure 3A). Consistent with a previous observation (Moon
et al., 2015), our study also demonstrated that ATP treatment
greatly induced the activation of AMPK. Both mTORC1 and
AMPK are key regulators of energy metabolism. Under nutrition
or other stresses, AMPK is activated (Hardie, 2011b). Multiple
cellular activities can be regulated by AMPK activation (Hardie,
2011a). For example, AMPK phosphorylates and inhibits the
activity of acetyl-CoA carboxylase (ACC), an enzyme responsible
for the catalysis of acetyl-CoA into malonyl-CoA during the
β-oxidation of fatty acids (Ha et al., 1994; Hardie and Pan, 2002).
It also inhibits the activity of mTORC1 by phosphorylation of
TSC2 (a suppressor of mTORC1) and Raptor [one member of
mTORC1 (Inoki et al., 2003; Gwinn et al., 2008)]. This leads
to a general inhibition of protein translation (Hardie, 2011a;
Thoreen et al., 2012). In the innate immunity, AMPK activation
in macrophages and neutrophils enhances their phagocytosis
ability against pathogens (Bae H. B. et al., 2011). Interestingly,
AMPK signaling can be suppressed by LPS, fatty acid and
other inflammatory stimulators (Yang et al., 2010). However,
it can be dramatically re-activated when a second DAMP
signal (such as ATP) is added, accompanied by inflammasome
assembly (Moon et al., 2015). Under this circumstance, the
cells resort to HK1-dependent glycolysis upon inflammasome
activation (Moon et al., 2015). This means that there is a sharp
switch of energy metabolism from oxidative phosphorylation
to glycolysis during the process of inflammasome activation
(including the progression phases from LPS priming to
ATP stimulation). As mTORC1 can stabilize the hypoxia-
induced factor-1α (HIF-1α), it favors cell survival in LPS-
primed macrophages (Gilroy and Yona, 2015). However, AMPK
activation, through suppressing mTORC1 activity, decreases the
level of HIF-1α and makes the cells undergo death processes
(Jiang et al., 2001; McGettrick and O’Neill, 2013). Although
piperine treatment seemed unable to reverse the suppression of
mTORC1 activity (as reflected by p70S6K phosphorylation) by
ATP, it significantly suppressed ATP-induced AMPK activation
(Figure 3A). This implies that piperine attenuated the inhibitory
activity of AMPK on mTORC1 signaling upon ATP treatment.
In addition, metformin (acting as an AMPK agonist) could
counteract the effect of piperine on reducing ATP-induced
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FIGURE 6 | Piperine administration reduced systemic IL-1β release in mouse bacterial sepsis. Piperine was suspended in 2% Tween-80 in PBS at a
concentration of 1 mg/ml. C57BL/6 mice (5 per group for each time point) were administered with piperine (20 mg/kg) or vehicle via gavage once a day for five
consecutive days and injected intraperitoneally (i.p.) with viable E. coli (2 × 109 CFU/mouse, in 0.5 ml PBS) 1 h after the last gavage. Peritoneal lavage fluids were
collected with 1 ml of PBS. Serum was isolated from retro-orbital blood sample. Soluble IL-1β was evaluated by CBA (cytometric bead array) according the
manufacturer’s instruction. (A) The levels of soluble IL-1β in peritoneal lavage fluids at 2, 4, and 8 h post bacterial infection. Data are presented as mean ± SD
(n = 5). (B) The serum levels of IL-1β at 6 and 12 h post bacterial infection. Data are presented as mean ± SD (n = 5). The significance was analyzed with unpaired
Student’s t-test. (C) A middle colon section with a length of 1 centimeter was cut from each mouse and immediately lysed by grinding with 500 µl 2x SDS-PAGE
loading buffer. Western blotting was used to detect the expression of pro-IL-1β and IL-1β in the colonic cell lysates. β-Actin was used as a loading control. Blots of
three mice from each group are shown. (D,E) Relative gray values of pro-IL-1β (D) and IL-1β in (E) were analyzed by one-way ANOVA with Tukey post hoc test. Data
are shown as mean ± SD (n = 3). ∗P < 0.05, ∗∗∗P < 0.001.
pyroptosis. These results suggested that suppressing AMPK
activation by piperine (or by other AMPK inhibitors) during
systemic bacterial infection may be helpful for preventing the
pathological development of sepsis. However, more research
is warranted to reveal whether piperine ameliorates other
inflammatory diseases, including epilepsy, obesity, arthritis and
ulcer by the common mechanism of inflammasome suppression
as in bacterial sepsis.
Piperine is the major plant alkaloid in pepper, a daily used food
seasoning. Therefore, it is believed to be low toxic to mammalian
cells and human body. Indeed, our preliminary experiments
showed that piperine had no overt toxicity to mouse BMDMs
at a dose up to 160 µM ex vivo and to mice at a dose up to
40 mg/kg/day in vivo. Supporting this, a previous study showed
that piperine has no oral acute toxicity on mice at a dose up to
5000 mg/kg (Gupta et al., 2015). This means that piperine may
be safe for humans at doses above tens of milligrams based on
translating dosages from animal models to human clinical trials
(Blanchard and Smoliga, 2015). Although there are currently no
clinical trials testing piperine for bacterial sepsis, other clinical
trials have recruited piperine at doses of 20–25 mg each time
or per day1. Another clinical trial had used piperine locally at 1
and 0.15 mM to evaluate the effect of piperine in patients with
oropharyngeal dysphagia2. Thus, the in vitro and in vivo doses
1http://clinicaltrialsfeeds.org/clinical-trials/results/term=Piperine
2https://clinicaltrials.gov/show/NCT01383694
used in this study have relevance for translating into human
study.
In summary, we revealed that piperine treatment could
significantly reduce ATP-induced pyroptosis in macrophages
probably through the suppression of AMPK signaling. In a
murine bacterial sepsis model, piperine administration sharply
decreased systemic IL-1β levels, suggestive of suppression of
systemic inflammation and pyroptosis. Our data highlight that
piperine may act as a suppressant of pyroptosis to exhibit its
therapeutic effects on bacterial sepsis and other inflammatory
disorders, which deserves further clinical investigation.
AUTHOR CONTRIBUTIONS
Y-DL, W-JB, C-GL, L-HX, and H-XW performed the
experiments. D-YO and X-HH designed the research. Y-DL,
C-GL, and HP analyzed the data. D-YO, X-HH, and Y-DL
wrote the paper. All authors approved the final version of the
manuscript.
ACKNOWLEDGMENTS
This work was supported by the grants from the National Natural
Science Foundation of China (No. 81373423, No. 81673664 and
No. 81173604).
Frontiers in Pharmacology | www.frontiersin.org 10 October 2016 | Volume 7 | Article 390
fphar-07-00390 October 18, 2016 Time: 14:46 # 11
Liang et al. Suppression of Pyroptosis by Piperine
REFERENCES
Aziz, M., Jacob, A., and Wang, P. (2014). Revisiting caspases in sepsis. Cell Death
Dis. 5:e1526. doi: 10.1038/cddis.2014.488
Bae, G. S., Kim, M. S., Jeong, J., Lee, H. Y., Park, K. C., Koo, B. S., et al. (2011).
Piperine ameliorates the severity of cerulein-induced acute pancreatitis by
inhibiting the activation of mitogen activated protein kinases. Biochem. Biophys.
Res. Commun. 410, 382–388. doi: 10.1016/j.bbrc.2011.05.136
Bae, H. B., Zmijewski, J. W., Deshane, J. S., Tadie, J. M., Chaplin, D. D.,
Takashima, S., et al. (2011). AMP-activated protein kinase enhances the
phagocytic ability of macrophages and neutrophils. FASEB J. 25, 4358–4368.
doi: 10.1096/fj.11-190587
Bae, G. S., Kim, M. S., Jung, W. S., Seo, S. W., Yun, S. W., Kim, S. G., et al. (2010).
Inhibition of lipopolysaccharide-induced inflammatory responses by piperine.
Eur. J. Pharmacol. 642, 154–162. doi: 10.1016/j.ejphar.2010.05.026
Bai, Y. F., and Xu, H. (2000). Protective action of piperine against experimental
gastric ulcer. Acta Pharmacol. Sin. 21, 357–359.
Blanchard, O. L., and Smoliga, J. M. (2015). Translating dosages from animal
models to human clinical trials–revisiting body surface area scaling. FASEB J.
29, 1629–1634. doi: 10.1096/fj.14-269043
BrahmaNaidu, P., Nemani, H., Meriga, B., Mehar, S. K., Potana, S., and
Ramgopalrao, S. (2014). Mitigating efficacy of piperine in the physiological
derangements of high fat diet induced obesity in Sprague Dawley rats. Chem.
Biol. Interact. 221, 42–51. doi: 10.1016/j.cbi.2014.07.008
Ceballos-Olvera, I., Sahoo, M., Miller, M. A., Del Barrio, L., and Re, F. (2011).
Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia
pseudomallei lung infection while IL-1beta is deleterious. PLoS Pathog.
7:e1002452. doi: 10.1371/journal.ppat.1002452
Cullen, S. P., Kearney, C. J., Clancy, D. M., and Martin, S. J. (2015).
Diverse activators of the NLRP3 inflammasome promote IL-1beta secretion
by triggering necrosis. Cell Rep. 11, 1535–1548. doi: 10.1016/j.celrep.2015.
05.003
de Souza, A. W., Westra, J., Limburg, P. C., Bijl, M., and Kallenberg, C. G.
(2012). HMGB1 in vascular diseases: its role in vascular inflammation and
atherosclerosis. Autoimmun. Rev. 11, 909–917. doi: 10.1016/j.autrev.2012.
03.007
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., et al.
(2013). Surviving sepsis campaign: international guidelines for management
of severe sepsis and septic shock, 2012. Intensive Care Med. 39, 165–228. doi:
10.1007/s00134-012-2769-8
Demon, D., Kuchmiy, A., Fossoul, A., Zhu, Q., Kanneganti, T. D., and Lamkanfi, M.
(2014). Caspase-11 is expressed in the colonic mucosa and protects against
dextran sodium sulfate-induced colitis. Mucosal Immunol. 7, 1480–1491. doi:
10.1038/mi.2014.36
Di, X., Wang, X., Di, X., and Liu, Y. (2015). Effect of piperine on the bioavailability
and pharmacokinetics of emodin in rats. J. Pharm. Biomed. Anal. 115, 144–149.
doi: 10.1016/j.jpba.2015.06.027
Dong, Y., Huihui, Z., and Li, C. (2015). Piperine inhibit inflammation, alveolar
bone loss and collagen fibers breakdown in a rat periodontitis model.
J. Periodont. Res. 50, 758–765. doi: 10.1111/jre.12262
Gdynia, G., Sauer, S. W., Kopitz, J., Fuchs, D., Duglova, K., Ruppert, T., et al.
(2016). The HMGB1 protein induces a metabolic type of tumour cell death
by blocking aerobic respiration. Nat. Commun. 7:10764. doi: 10.1038/ncomms
10764
Gilroy, D. W., and Yona, S. (2015). HIF1alpha allows monocytes to take a breather
during sepsis. Immunity 42, 397–399. doi: 10.1016/j.immuni.2015.02.016
Gupta, R. A., Motiwala, M. N., Dumore, N. G., Danao, K. R., and Ganjare,
A. B. (2015). Effect of piperine on inhibition of FFA induced TLR4 mediated
inflammation and amelioration of acetic acid induced ulcerative colitis in mice.
J. Ethnopharmacol. 164, 239–246. doi: 10.1016/j.jep.2015.01.039
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez,
D. S., et al. (2008). AMPK phosphorylation of raptor mediates a metabolic
checkpoint. Mol. Cell 30, 214–226. doi: 10.1016/j.molcel.2008.03.003
Ha, J., Daniel, S., Broyles, S. S., and Kim, K. H. (1994). Critical phosphorylation
sites for acetyl-CoA carboxylase activity. J. Biol. Chem. 269, 22162–22168.
Hardie, D. G. (2011a). AMP-activated protein kinase: an energy sensor that
regulates all aspects of cell function. Genes Dev. 25, 1895–1908. doi: 10.1101/
gad.17420111
Hardie, D. G. (2011b). Sensing of energy and nutrients by AMP-activated protein
kinase. Am. J. Clin. Nutr. 93, 891S–896S. doi: 10.3945/ajcn.110.001925
Hardie, D. G., and Pan, D. A. (2002). Regulation of fatty acid synthesis and
oxidation by the AMP-activated protein kinase. Biochem. Soc. Trans. 30, 1064–
1070. doi: 10.1042/bst0301064
Hu, Z., Murakami, T., Suzuki, K., Tamura, H., Reich, J., Kuwahara-Arai, K.,
et al. (2016). Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis
of macrophages and improves the survival of polybacterial septic mice. Int.
Immunol. 28, 245–253. doi: 10.1093/intimm/dxv113
Inoki, K., Zhu, T., and Guan, K. L. (2003). TSC2 mediates cellular energy response
to control cell growth and survival. Cell 115, 577–590. doi: 10.1016/S0092-
8674(03)00929-2
Jiang, B. H., Jiang, G., Zheng, J. Z., Lu, Z., Hunter, T., and Vogt, P. K. (2001).
Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible
factor 1. Cell Growth Differ. 12, 363–369.
Johnson, J. J., Nihal, M., Siddiqui, I. A., Scarlett, C. O., Bailey, H. H., Mukhtar, H.,
et al. (2011). Enhancing the bioavailability of resveratrol by combining it with
piperine. Mol. Nutr. Food Res. 55, 1169–1176. doi: 10.1002/mnfr.201100117
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S.,
et al. (2015). Caspase-11 cleaves gasdermin D for non-canonical inflammasome
signalling. Nature 526, 666–671. doi: 10.1038/nature15541
Kayagaki, N., Warming, S., Lamkanfi, M., Vande Walle, L., Louie, S., Dong, J., et al.
(2011). Non-canonical inflammasome activation targets caspase-11. Nature
479, 117–121. doi: 10.1038/nature10558
Kayagaki, N., Wong, M. T., Stowe, I. B., Ramani, S. R., Gonzalez, L. C.,
Akashi-Takamura, S., et al. (2013). Noncanonical inflammasome activation
by intracellular LPS independent of TLR4. Science 341, 1246–1249. doi:
10.1126/science.1240248
Lamkanfi, M., and Dixit, V. M. (2014). Mechanisms and functions of
inflammasomes. Cell 157, 1013–1022. doi: 10.1016/j.cell.2014.04.007
Lamkanfi, M., Vande Walle, L., and Kanneganti, T. D. (2011). Deregulated
inflammasome signaling in disease. Immunol. Rev. 243, 163–173. doi:
10.1111/j.1600-065X.2011.01042.x
Latz, E., Xiao, T. S., and Stutz, A. (2013). Activation and regulation of the
inflammasomes. Nat. Rev. Immunol. 13, 397–411. doi: 10.1038/nri3452
Lin, Q. R., Li, C. G., Zha, Q. B., Xu, L. H., Pan, H., Zhao, G. X., et al.
(2016). Gossypol induces pyroptosis in mouse macrophages via a non-
canonical inflammasome pathway. Toxicol. Appl. Pharmacol. 292, 56–64. doi:
10.1016/j.taap.2015.12.027
Maltez, V. I., Tubbs, A. L., Cook, K. D., Aachoui, Y., Falcone, E. L., Holland,
S. M., et al. (2015). Inflammasomes coordinate pyroptosis and natural killer
cell cytotoxicity to clear infection by a ubiquitous environmental bacterium.
Immunity 43, 987–997. doi: 10.1016/j.immuni.2015.10.010
Mao, Q. Q., Huang, Z., Zhong, X. M., Xian, Y. F., and Ip, S. P. (2014). Brain-
derived neurotrophic factor signalling mediates the antidepressant-like effect
of piperine in chronically stressed mice. Behav. Brain Res. 261, 140–145. doi:
10.1016/j.bbr.2013.12.020
Masters, S. L., Gerlic, M., Metcalf, D., Preston, S., Pellegrini, M., O’Donnell,
J. A., et al. (2012). NLRP1 inflammasome activation induces pyroptosis
of hematopoietic progenitor cells. Immunity 37, 1009–1023. doi: 10.1016/
j.immuni.2012.08.027
McGettrick, A. F., and O’Neill, L. A. (2013). How metabolism generates signals
during innate immunity and inflammation. J. Biol. Chem. 288, 22893–22898.
doi: 10.1074/jbc.R113.486464
Mehmood, M. H., and Gilani, A. H. (2010). Pharmacological basis for the medicinal
use of black pepper and piperine in gastrointestinal disorders. J. Med. Food 13,
1086–1096. doi: 10.1089/jmf.2010.1065
Mempin, R., Tran, H., Chen, C., Gong, H., Kim Ho, K., and Lu, S. (2013). Release
of extracellular ATP by bacteria during growth. BMC Microbiol. 13:301. doi:
10.1186/1471-2180-13-301
Moon, J. S., Hisata, S., Park, M. A., DeNicola, G. M., Ryter, S. W.,
Nakahira, K., et al. (2015). mTORC1-induced HK1-dependent glycolysis
regulates NLRP3 inflammasome activation. Cell Rep. 12, 102–115. doi:
10.1016/j.celrep.2015.05.046
Murunikkara, V., Pragasam, S. J., Kodandaraman, G., Sabina, E. P., and Rasool, M.
(2012). Anti-inflammatory effect of piperine in adjuvant-induced arthritic rats–
a biochemical approach. Inflammation 35, 1348–1356. doi: 10.1007/s10753-
012-9448-3
Frontiers in Pharmacology | www.frontiersin.org 11 October 2016 | Volume 7 | Article 390
fphar-07-00390 October 18, 2016 Time: 14:46 # 12
Liang et al. Suppression of Pyroptosis by Piperine
Oficjalska, K., Raverdeau, M., Aviello, G., Wade, S. C., Hickey, A., Sheehan, K. M.,
et al. (2015). Protective role for caspase-11 during acute experimental murine
colitis. J. Immunol. 194, 1252–1260. doi: 10.4049/jimmunol.1400501
Pal, A., Nayak, S., Sahu, P. K., and Swain, T. (2011). Piperine protects epilepsy
associated depression: a study on role of monoamines. Eur. Rev. Med.
Pharmacol. Sci. 15, 1288–1295.
Pan, H., Xu, L. H., Huang, M. Y., Zha, Q. B., Zhao, G. X., Hou, X. F., et al. (2015).
Piperine metabolically regulates peritoneal resident macrophages to potentiate
their functions against bacterial infection. Oncotarget 6, 32468–32483. doi:
10.18632/oncotarget.5957
Py, B. F., Jin, M., Desai, B. N., Penumaka, A., Zhu, H., Kober, M., et al. (2014).
Caspase-11 controls interleukin-1beta release through degradation of TRPC1.
Cell Rep. 6, 1122–1128. doi: 10.1016/j.celrep.2014.02.015
Ren, H., Teng, Y., Tan, B., Zhang, X., Jiang, W., Liu, M., et al. (2014). Toll-
like receptor-triggered calcium mobilization protects mice against bacterial
infection through extracellular ATP release. Infect. Immun. 82, 5076–5085. doi:
10.1128/iai.02546-14
Samra, Y. A., Said, H. S., Elsherbiny, N. M., Liou, G. I., El-Shishtawy, M. M.,
and Eissa, L. A. (2016). Cepharanthine and Piperine ameliorate diabetic
nephropathy in rats: role of NF-kappaB and NLRP3 inflammasome. Life Sci.
157, 187–199. doi: 10.1016/j.lfs.2016.06.002
Shi, J., Zhao, Y., Wang, Y., Gao, W., Ding, J., Li, P., et al. (2014). Inflammatory
caspases are innate immune receptors for intracellular LPS. Nature 514, 187–
192. doi: 10.1038/nature13683
Su, K. H., and Dai, C. (2016). Metabolic control of the proteotoxic stress response:
implications in diabetes mellitus and neurodegenerative disorders. Cell Mol. Life
Sci. 73, 4231–4248. doi: 10.1007/s00018-016-2291-1
Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., and Sabatini,
D. M. (2012). A unifying model for mTORC1-mediated regulation of mRNA
translation. Nature 485, 109–113. doi: 10.1038/nature11083
Umar, S., Golam Sarwar, A. H., Umar, K., Ahmad, N., Sajad, M., Ahmad, S., et al.
(2013). Piperine ameliorates oxidative stress, inflammation and histological
outcome in collagen induced arthritis. Cell Immunol. 284, 51–59. doi:
10.1016/j.cellimm.2013.07.004
Vande Walle, L., Van Opdenbosch, N., Jacques, P., Fossoul, A., Verheugen, E.,
Vogel, P., et al. (2014). Negative regulation of the NLRP3 inflammasome by
A20 protects against arthritis. Nature 512, 69–73. doi: 10.1038/nature13322
Wang, Y., Viollet, B., Terkeltaub, R., and Liu-Bryan, R. (2016). AMP-activated
protein kinase suppresses urate crystal-induced inflammation and transduces
colchicine effects in macrophages. Ann. Rheum. Dis. 75, 286–294. doi: 10.1136/
annrheumdis-2014-206074
Wattanathorn, J., Chonpathompikunlert, P., Muchimapura, S., Priprem, A.,
and Tankamnerdthai, O. (2008). Piperine, the potential functional food for
mood and cognitive disorders. Food Chem. Toxicol. 46, 3106–3110. doi:
10.1016/j.fct.2008.06.014
Wegiel, B., Larsen, R., Gallo, D., Chin, B. Y., Harris, C., Mannam, P., et al. (2014).
Macrophages sense and kill bacteria through carbon monoxide-dependent
inflammasome activation. J. Clin. Invest. 124, 4926–4940. doi: 10.1172/jci
72853
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T., et al. (2011). Fatty
acid-induced NLRP3-ASC inflammasome activation interferes with insulin
signaling. Nat. Immunol. 12, 408–415. doi: 10.1038/ni.2022
Wree, A., Eguchi, A., McGeough, M. D., Pena, C. A., Johnson, C. D., Canbay, A.,
et al. (2014). NLRP3 inflammasome activation results in hepatocyte pyroptosis,
liver inflammation, and fibrosis in mice. Hepatology 59, 898–910. doi:
10.1002/hep.26592
Yang, C. A., and Chiang, B. L. (2015). Inflammasomes and human autoimmunity:
a comprehensive review. J. Autoimmun. 61, 1–8. doi: 10.1016/j.jaut.2015.
05.001
Yang, Z., Kahn, B. B., Shi, H., and Xue, B. Z. (2010). Macrophage alpha1
AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced
inflammation through SIRT1. J. Biol. Chem. 285, 19051–19059. doi:
10.1074/jbc.M110.123620
Ying, X., Chen, X., Cheng, S., Shen, Y., Peng, L., and Xu, H. Z. (2013).
Piperine inhibits IL-beta induced expression of inflammatory mediators in
human osteoarthritis chondrocyte. Int. Immunopharmacol. 17, 293–299. doi:
10.1016/j.intimp.2013.06.025
Zaki, M. H., Boyd, K. L., Vogel, P., Kastan, M. B., Lamkanfi, M., and Kanneganti,
T. D. (2010). The NLRP3 inflammasome protects against loss of epithelial
integrity and mortality during experimental colitis. Immunity 32, 379–391. doi:
10.1016/j.immuni.2010.03.003
Zhang, Y., Zheng, Y., and Li, H. (2016). NLRP3 inflammasome plays an important
role in the pathogenesis of collagen-induced arthritis. Mediators Inflamm.
2016:9656270. doi: 10.1155/2016/9656270
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Liang, Bai, Li, Xu, Wei, Pan, He and Ouyang. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Pharmacology | www.frontiersin.org 12 October 2016 | Volume 7 | Article 390
